Case Studies & Scientific Benchmarks
Anonymized client engagements delivered under NDA alongside clearly labelled primary research benchmarks from our founding scientific leadership.
PRISMA 2020 Systematic Review & GRADE Certainty Appraisal in Obstetrics
12–14 week end-to-end PRISMA 2020 systematic review for a clinician-investigator: reproducible database search strings, blinded dual-reviewer screening in Rayyan, Cochrane Risk-of-Bias appraisal, and GRADE outcome profiles.
Cross-Species Single-Cell RNA-Seq Integration for Neuroscience Target Discovery
8–10 week bioinformatics and scientific writing engagement for a neuroscience research group: QC, batch-corrected cross-species scRNA-seq integration, conserved cell-state target prioritization, and grant-ready figures.
Founder Research Benchmark: iTRAQ Quantitative Proteomics & Complement Pathway Inhibition in Inflammatory Arthritis
Published multi-institution academic study led by Dr. Debasis Sahu (First Author, Front. Cell Dev. Biol. 2022;10:845457) using iTRAQ quantitative proteomics and network pharmacology in an adjuvant-induced arthritis rat model.